CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.

50 Although not reaching statistical significance, all three markers, CCL2, CCR2 and CCR4, showed a trend towards higher expression in the tumours that later metastasized to the brain ( Fig. 2K–M ).

also in 53,322 other papers